Trial Profile
Randomised, Double-blind, Single Dose, Three-way, Cross-over Study to Investigate the Safety and Response to 1g or 2g Rectal Suppositories Containing 5 mg or 10 mg 1R,2S-methoxamine Hydrochloride [NRL001] or Matching Placebo
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Jun 2014
Price :
$35
*
At a glance
- Drugs Methoxamine (Primary)
- Indications Faecal incontinence
- Focus Pharmacodynamics
- Acronyms SUM
- Sponsors Norgine
- 04 Jun 2014 New trial record